Labcorp Holdings Inc.
LH
NYSE
258.39
USD-3.09(-1.18%)
As of today
Labcorp Holdings Inc. fundamentals
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 13,978,500,000 | 13,136,100,000 | 11,863,900,000 | 12,161,600,000 | 13,008,900,000 | |
| Gross Profit | 4,952,800,000 | 4,992,400,000 | 3,708,900,000 | 3,364,900,000 | 3,624,400,000 | |
| Operating Income | 2,445,400,000 | 3,048,600,000 | 1,436,500,000 | 725,600,000 | 1,086,700,000 | |
| Net Income | 1,556,100,000 | 2,377,300,000 | 1,279,100,000 | 418,000,000 | 746,000,000 | |
| Total Assets | 20,071,700,000 | 20,385,400,000 | 20,155,100,000 | 16,725,100,000 | 18,379,000,000 | |
| Total Current Liabilities | 3,078,500,000 | 2,782,900,000 | 3,078,500,000 | 3,225,200,000 | 3,330,200,000 | |
| Total Equity | 9,457,300,000 | 10,294,000,000 | 10,115,500,000 | 7,890,500,000 | 8,066,500,000 | |
| Free Cash Flow | 1,753,600,000 | 2,649,200,000 | 1,474,000,000 | 874,100,000 | 1,095,900,000 | |
| Cash from Operations | 2,135,300,000 | 3,109,600,000 | 1,955,900,000 | 1,327,700,000 | 1,585,800,000 | |
| Cash from Investing | -643,200,000 | -884,600,000 | -1,652,200,000 | -1,171,500,000 | -1,366,800,000 | |
| Cash from Financing | -517,400,000 | -2,065,800,000 | -1,322,200,000 | -59,300,000 | 779,900,000 | |
| Net Change in Cash | 983,300,000 | 151,900,000 | -1,042,700,000 | 106,800,000 | 981,900,000 |